Glafenine

DB08963ApprovedWithdrawnSmall molecule

An anthranilic acid derivative with analgesic properties used for the relief of all types of pain. Glafenine is withdrawn from the American market.

Chemical structure of Glafenine
Mechanism
Curator reviewed
Formula / weight
C19H17ClN2O4 · 372.802 g/mol (avg)
Also known as
Glycerylaminophenaquine
Code names
R-1707

Resolves to

Compound
UNII46HL4I09AHCAS3820-67-5ChEMBLCHEMBL146095ChEBI31653KEGGD01351
Clinical / RWD
ATCN02BG03
Structure
InChIKeyGWOFUCIGLDBNKM-UHFFFAOYSA-NSMILESOCC(O)COC(=O)C1=C(NC2=C3C=CC(Cl)=CC3=NC=C2)C=CC=C1

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
558Drug interactionsStructured to mechanism, not free text
Sign in
1ATC codeIncluding every combination product, plus 13 drug categories
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which companies are running trials of Glafenine, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In